HPV in the Young Population: New Perspectives in Clinical Practice from Vaccination to Screening
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Human Papillomavirus Vaccines".
Deadline for manuscript submissions: 15 August 2024 | Viewed by 751
Special Issue Editors
2. Department of Obstetrics and Gynecology, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy
Interests: HPV; lower genital tract disease; vaccination
Special Issues, Collections and Topics in MDPI journals
Interests: HPV; lower genital tract disease; vaccination
2. Department of Obstetrics and Gynecology, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy
Interests: HPV; lower genital tract disease; vaccination
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The introduction of HPV vaccination can prevent the development of HPV-related diseases of the genital tract. Ideally, young people should receive the vaccine before becoming sexually active. Those who are already sexually active may still benefit from immunization, since few young people are infected by all HPV strains. It is important to understand the natural history of HPV infection in order to understand the impact of infection on this population. This understanding can help promote vaccination and adherence to screening programs.
This Special Issue covers all topics related to HPV in clinical practice from vaccination to screening, and focuses on studies examining the significance of vaccines/therapeutic vaccines in the management of disease. Manuscripts of different types, including long comprehensive research articles or reviews, will be considered for publication in this Special Issue. All submissions will undergo rigorous peer review.
Dr. Mattia Dominoni
Dr. Lucia Merlino
Dr. Barbara Gardella
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- HPV
- younger people
- vaccination
- cervical intraepithelial neoplasia (CIN)
- experimental HPV vaccines
- therapeutic HPV vaccines
